Cagdas Sahin

Cagdas Sahin

Auto-generated profile, based on publicly available information

Cagdas Sahin

Ege University, Faculty School of Medicine, Department of Obstetrics and Gynecology

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2018 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
CSCagdas Sahin
Cagdas Sahin
RMRamanaiah Mamillapalli
Ramanaiah Mamillapalli
KYKyong W. Yi
Kyong W. Yi
HTHugh S. Taylor
Hugh S. Taylor
Endometriosis is an oestrogen‐dependent, chronic inflammatory disease that affects 10% of reproductive‐aged women. Current treatment options depend on female sex steroid hormone modulation; however, all have side effects and are not useful in women who want to conceive. microRNAs treatments have provided promising results for some chronic diseases and cancers. We have previously shown the microRNA Let‐7b is repressed in endometriosis and that loss of Let‐7 contributes to the pathophysiology of the disease. Here, we propose using microRNA Let‐7b for the treatment of endometriosis in a murine model. Endometriosis was treated using microRNA Let‐7b or a scrambled control microRNA. Let‐7b treatment resulted in reduced endometriosis lesion size. Decreased gene expression was noted in several genes known to promote endometriosis growth including ER‐α, ER‐ß, Cyp19a, KRAS 4A, KRAS 4B and IL‐6. These results indicate that microRNA Let‐7b has a pleiotropic role in endometriosis pathophysiology affecting oestrogen signalling, inflammation and growth factor receptors. Local treatment of endometriosis with Let‐7b is a promising therapy for endometriosis that simultaneously affects multiple pathways driving endometriosis without systemic hormonal side effects.

1 August 2018 in Biology of Reproduction
Verified
Journal Article
Closed access
PDF file
KYKyong Wook Yi
Kyong Wook Yi
RMRamanaiah Mamillapalli
Ramanaiah Mamillapalli
CSCagdas Sahin
Cagdas Sahin
JSJae Yen Song
Jae Yen Song
RTReshef Tal
Reshef Tal
HTHugh S Taylor
Hugh S Taylor
Successful implantation and pregnancy is dependent on sufficient endometrial growth during each reproductive cycle. Here we report the therapeutic effect of either bone marrow-derived cells or the stem cell chemo-attractant CXCL12 on endometrial receptivity in a murine ethanol induced thin endometrium model. Endometrial epithelial area was significantly increased in mice treated with BMDCs, CXCL12 or by co-treatment with both compared with PBS treated controls. Ki-67 and CD31 immunoreactivity was significantly higher in mice treated with either BMDCs, CXCL12 or both. The mRNA expression levels of endometrial receptivity markers leukemia inhibitory factor, interleukin-1β, and integrin beta-3 were increased in mice treated with either BMDCs, CXCL12 or both. The mRNA levels of matrix metalloproteinase-2 and -9 were significantly decreased by BMDCs but not by CXCL12. Pregnancy rates and litter size were increased after either treatment. Both BMDCs and CXCL12 displayed a comparable efficacy on endometrial regeneration in mice with thin endometrium. Our findings indicate the potential therapeutic effects of BMDCs and CXCL12 on infertility related to thin endometrium.

1 February 2018 in Analytical Biochemistry
Verified
Journal Article
Closed access
ZUZihni Onur Uygun
Zihni Onur Uygun
ÇŞÇağdaş Şahin
Çağdaş Şahin
MYMerve Yılmaz
Merve Yılmaz
YAYasemin Akçay
Yasemin Akçay
AAAli Akdemir
Ali Akdemir
FSFerhan Sağın
Ferhan Sağın

1 October 2019 in Reproductive Sciences
Verified
Journal Article
Closed access
IHIsmet Hortu
Ismet Hortu
GOGokay Ozceltik
Gokay Ozceltik
CSCagdas Sahin
Cagdas Sahin
LALevent Akman
Levent Akman
NYNuri Yildirim
Nuri Yildirim
OEOytun Erbas
Oytun Erbas

1 June 2015 in International Journal of Surgery
Verified
Journal Article
Closed access
AOAykut Ozcan
Aykut Ozcan
ETemrah töz
emrah töz
VTVolkan Turan
Volkan Turan
CSCagdas Sahin
Cagdas Sahin
AKAycan Kopuz
Aycan Kopuz
MSMUZAFFER SANCI
MUZAFFER SANCI
The aim of this study was to determine how often the appendix is involved or the primary source of cancer in women undergoing surgery for mucinous borderline ovarian tumour (mBOT) or invasive mucinous ovarian tumour (IMOT) and to evaluate whether appendectomy is necessary. The hospital database was searched for women who underwent surgery and whose final diagnosis was mBOT, IMOT or mucinous appendix carcinoma between 1998 and 2014. One hundred and twenty-nine cases were identified, including 69 mBOT, 51 IMOT and nine primary mucinous appendix carcinomas. Of 97 appendectomies performed, nine lymphoid hyperplasia, two mucocele, one carcinoid tumour of the appendix, one mucinous tumour metastasis from the ovary and nine primary mucinous appendix carcinomas were found and all appendices were grossly abnormal. No recurrence was seen during the follow-up period in 28 patients who had no appendectomy performed for grossly normal appendix. Pathologic diagnosis was normal in all 65 patients whose appendix was noted to be grossly normal and who underwent appendectomy. No recurrence was detected during a median follow-up period of 7 years (range 1-16 years).Sensitivity, specificity, positive and negative predictive value of the macroscopic appearance of the appendix were 100%, 86.67%, 56.52% and 100.00%, respectively. If the appendix is grossly normal, it appears unnecessary to perform an appendectomy in patients operated for an adnexal mass and whose frozen section analysis was reported as mBOT or IMOT. Appendectomy should not be performed if the appendix is grossly normal.

1 November 2014 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
VTVolkan Turan
Volkan Turan
AKAycan Kopuz
Aycan Kopuz
AOAykut Ozcan
Aykut Ozcan
BKBetul Kocakaya
Betul Kocakaya
CSCagdas Sahin
Cagdas Sahin
USUlas Solmaz
Ulas Solmaz